查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1808274

横向流动化验市场（按产品类型、样本类型、格式、方法、应用和最终用户划分）—全球预测，2025-2030 年

Lateral Flow Assays Market by Product Type, Sample Type, Format, Technique, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计横向流动化验市场规模在 2024 年将达到 104.9 亿美元，2025 年将达到 111.6 亿美元，2030 年将达到 154.8 亿美元，复合年增长率为 6.69%。

主要市场统计数据
基准年2024年 104.9亿美元
预计2025年 111.6亿美元
预测年份 2030 154.8亿美元
复合年增长率（%） 6.69%

揭示了横向流动化验在革新照护现场诊断和在新兴医疗环境中实现快速检测的关键作用

横向流动化验已迅速发展成为照护现场诊断的支柱技术，为医疗保健和商业环境中快速、低成本且用户友好的检测提供了一个多功能平台。该检测法最初开发用于妊娠检测，现已扩展到传染病筛检、药物滥用检测、心臟标记评估和环境监测等领域。其易于使用、极低的培训成本和快速的检测结果，使其在诊断实验室、医院、居家照护机构和研究机构中广泛应用。随着全球医疗保健系统专注于分散检测和早期发现，横向流动化验能够提供快速、可操作的结果，以支持及时的临床决策。

探索塑造横向流动化验市场和推动样品分析和检测技术创新的关键变革力量

在数位创新、先进材料科学和整合互联的推动下，横向流动化验领域正在经历一场变革。首先，配备人工智慧演算法的新一代读取器的出现，透过实现自动化影像分析、即时结果解读和云端基础资料聚合，提升了侦测效能。同时，新型奈米材料和增强型偶联化学技术的采用，提高了其与实验室免疫测量的灵敏度，并扩大了可检测生物标记的频谱。

检验2025年美国关税对横向流动化验供应链、商业策略和全球贸易动态的多面向影响

2025年美国关税的实施对全球横向流动化验组件和成品的贸易动态产生了重大影响。依赖进口关键耗材（例如抗体、硝酸纤维素膜和塑胶外壳）的製造商面临着不断上升的投入成本，这影响了他们的定价策略和利润率。为此，许多供应商努力实现供应商网路多元化，与其他地区的合作伙伴合作，以确保以具有竞争力的价格稳定供应材料。

根据产品类型、样品类型、格式、方法、应用和最终用户解读核心细分洞察，为检测开发提供精准策略支援。

对于寻求精准成长机会和精准定位的相关人员来说，准确理解检测市场区隔至关重要。按产品类型分析，套件仍然是主要的收益驱动力，而领先产品凭藉数位化增强和连接功能正获得关注；在常规检测维护和品管需求的推动下，试剂和耗材的需求保持稳定。从样本类型来看，全血仍然在临床诊断中占据主导地位，但人们对唾液检测的兴趣日益浓厚，这反映出人们对非侵入性检测解决方案的追求。血清和血浆应用是脂质和胆固醇检测的基础，而尿液筛检对于药物滥用检测和感染疾病监测至关重要。

分析美洲、欧洲、中东和非洲以及亚太地区在需求、技术采用和法规环境的区域差异

区域动态在塑造横向流动化验市场的发展轨迹方面发挥关键作用。在美洲，强大的医疗基础设施和积极主动的监管机构正在推动创新照护现场技术的快速普及。公共卫生计画和报销框架持续鼓励分散式检查，支援在社区诊所和零售医疗中心广泛部署。跨境贸易协定同样促进了检测组件的分销，并加强了北美和拉丁美洲的合作研究网络。

主要企业的竞争定位和合作伙伴关係策略措施塑造了横向流动化验市场的未来

横向流动化验的竞争格局由成熟的诊断领导者、专业试剂供应商和灵活的新兴企业共同构成。大型诊断公司正在利用其广泛的分销网络，推出先进的读取系统和多重检测方案，并整合连接功能，以补充其传统的套件组合。同时，纯试剂製造商正致力于提高抗体特异性和膜技术，使最终用户能够获得更高的分析性能。新兴企业和利基市场参与者正在透过开拓新型标记剂（例如上转换磷光体和量子点）来扩大可检测标靶的范围，从而为市场注入活力。

为产业领导者提供可行的策略建议，以优化营运、利用新机会并推动横向流动化验的成长

为了因应不断发展的横向流动化验市场并确保竞争优势，产业领导者应优先考虑一系列策略行动。首先，投资数位读取技术和数据分析平台将为远端监控、患者参与和即时流行病学洞察带来新的机会。其次，透过近岸外包和跨区域设施实现製造地多元化，将降低关税风险并提高供应链的弹性。第三，与抗体和膜材料创新者建立合作伙伴关係，将缩短开发时间并提升专有检测方法的性能。

综合调查方法概述，结合定性和定量方法、专家访谈和数据三角测量，确保分析的严谨性

本分析所依据的研究采用了严格的多阶段方法，旨在确保洞察的广度和深度。首先，透过与50多位产业专家（包括研发主管、监管专家、采购经理和最终用户代表）进行深入访谈，收集了主要的定性资料。这些访谈提供了关于技术趋势、市场驱动因素和驱动因素以及营运挑战的细緻观点。同时，二次研究则涵盖了对同行评审学术期刊、监管出版物、专利申请和技术白皮书的全面审查，从而将定量市场指标与定性研究结果进行三角检验。

结论强调了动态横向流动化验领域相关人员的策略要务、创新途径和成长前景

摘要，在材料科学、数位整合和多路復用技术的推动下，横向流动化验处于快速诊断创新的前沿。 2025年关税的实施正在推动供应链多元化、近岸生产和采购优化，凸显了敏捷性和韧性的重要性。详细的細項分析揭示了按产品类型、样本基质、检测方式和应用领域分類的差异化成长路径，而区域洞察则突显了美洲、欧洲、中东和非洲以及亚太市场的策略差异。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章市场动态

  • 整合基于智慧型手机的定量读取器，用于多路復用横向流动化验，实现即时数据分析
  • 开发可生物降解且环保的横向流动化验膜以减少对环境的影响
  • 将基于 CRISPR 的讯号放大引入横向流动诊断，以提高就地检验的灵敏度
  • 使用多路復用横向流动平台扩展呼吸道病原体的家庭传染病检查面板
  • 将人工智慧驱动的影像分析引入横向流动测试读取器，以提高结果解释的准确性
  • 与中心实验室和横向流动化验製造商伙伴关係，以标准化品管通讯协定
  • 完全数位化供应链管理的出现，可快速交付横向流动化验组件
  • 使用横向流动测试进行慢性疾病管理中的生物标记监测的个人化医疗应用的成长

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

第 8 章横向流动化验市场（依产品类型）

  • 套件
  • 领导者
  • 试剂和耗材

第九章横向流动化验市场（依样本类型）

  • 唾液
  • 血清和血浆
  • 尿
  • 全血

第 10 章横向流动化验市场（依格式）

  • 卡式磁带
  • 条
  • 孔盘

第 11 章横向流动化验市场（依方法）

  • 竞争分析
  • 多重侦测
  • 夹心试验

第十二章横向流动化验市场（按应用）

  • 临床诊断
    • 心臟标记检测
    • 药物滥用检测
    • 感染疾病
    • 脂质/胆固醇测试
    • 妊娠和生育能力测试
  • 环境测试
  • 食品安全
  • 品管
  • 兽医检查

第十三章横向流动化验市场（依最终用户）

  • 诊断实验室
  • 居家照护
  • 医院和诊所
  • 就地检验
  • 研究所

14.美洲横向流动化验市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

15. 欧洲、中东和非洲横向流动化验市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

16. 亚太地区横向流动化验市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十七章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Abbott Laboratories
    • Abcam PLC by Danaher Corporation
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Bio-Techne Corporation
    • BioMerieux SA
    • BioPorto Diagnostics A/S
    • Cytodiagnostics Inc.
    • Danaher Corporation
    • Elabscience Bionovation Inc.
    • F. Hoffmann-La Roche Ltd.
    • Fortis Life Sciences
    • Hologic, Inc.
    • Merck KGaA
    • Microcoat Biotechnologie GmbH
    • PerkinElmer Inc.
    • Porex Corporation by Filtration Group Corporation
    • QIAGEN NV
    • QuidelOrtho Corporation
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Leinco Technologies, Inc.
    • R-Biopharm AG
    • Suzhou Vdo Biotech Co.,Ltd.
    • Rockland Immunochemicals, Inc.
    • BBI Solutions
    • BioFluidix GmbH by Hamilton Company
    • Tetracore, Inc.
    • Milenia Biotec GmbH
    • Shenzhen SEKBIO Co., Ltd.

第十八章 研究人工智慧

第十九章 研究统计

第二十章 研究联络人

第21章 研究报导

第22章 附录

Product Code: MRR-DD6333AE5DFB

The Lateral Flow Assays Market was valued at USD 10.49 billion in 2024 and is projected to grow to USD 11.16 billion in 2025, with a CAGR of 6.69%, reaching USD 15.48 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 10.49 billion
Estimated Year [2025] USD 11.16 billion
Forecast Year [2030] USD 15.48 billion
CAGR (%) 6.69%

Unveiling the Critical Role of Lateral Flow Assays in Revolutionizing Point-of-Care Diagnostics and Enabling Rapid Testing Across Emerging Healthcare Settings

Lateral flow assays have rapidly emerged as a cornerstone technology in point-of-care diagnostics, offering a versatile platform for rapid, low-cost, and user-friendly testing across healthcare and commercial settings. Originally developed for pregnancy testing, these assays have expanded into infectious disease screening, drug abuse detection, cardiac marker evaluation, and environmental monitoring. Their ease of use, combined with minimal training requirements and rapid time to result, has driven widespread adoption by diagnostic laboratories, hospitals, home care providers, and research institutes alike. As healthcare systems worldwide place greater emphasis on decentralized testing and early detection, lateral flow assays deliver quick actionable results that support timely clinical decision-making.

Moreover, ongoing innovations in assay chemistry, reader integration, and sample preparation techniques have significantly enhanced sensitivity and specificity. The integration of smartphone-based readers and portable devices has further democratized access to diagnostic data, enabling remote healthcare delivery and telemedicine applications. Consequently, market stakeholders are increasingly focusing on next-generation assay formats, multiplexing capabilities, and connectivity solutions. In parallel, regulatory bodies are streamlining approval pathways and establishing quality requirements that ensure robust performance standards. This convergence of technological advancement, regulatory evolution, and growing demand for decentralized testing creates a dynamic landscape in which lateral flow assays continue to redefine rapid diagnostics.

Exploring the Key Transformational Forces Reshaping the Lateral Flow Assay Market and Driving Innovation in Sample Analysis and Detection Technologies

The landscape of lateral flow assays is undergoing transformative shifts driven by the convergence of digital innovation, advanced materials science, and integrated connectivity. First, the emergence of next-generation readers equipped with artificial intelligence algorithms is elevating assay performance by enabling automated image analysis, real-time result interpretation, and cloud-based data aggregation. In tandem, the adoption of novel nanomaterials and enhanced conjugate chemistries is pushing analytical sensitivity to rival laboratory-based immunoassays, thereby broadening the spectrum of detectable biomarkers.

Furthermore, the integration of smartphone applications and Internet of Things connectivity is empowering end users with seamless data sharing, remote monitoring, and epidemiological tracking. These digital tools facilitate longitudinal patient management, outbreak surveillance, and supply chain optimization. Simultaneously, the rise of multiplex assay platforms allows simultaneous detection of multiple analytes within a single test, driving operational efficiency and reducing sample volume requirements. Additionally, tailored assay formats such as cassette, strip, and well plate configurations are aligning with diverse workflow needs-from field testing in environmental and food safety settings to high-throughput screening in clinical laboratories.

Collectively, these technological and operational advances are fostering a more agile, interconnected, and responsive ecosystem for lateral flow diagnostics. As a result, stakeholders are positioned to capitalize on emerging opportunities in personalized medicine, telehealth, and decentralized care models, setting the stage for sustained innovation and market expansion.

Examining the Multifaceted Impact of 2025 United States Tariffs on Lateral Flow Assay Supply Chains Commercial Strategies and Global Trade Dynamics

The implementation of tariffs by the United States in 2025 has markedly influenced the global trade dynamics of lateral flow assay components and finished devices. Manufacturers reliant on imports of critical consumables, including antibodies, nitrocellulose membranes, and plastic housing, confronted elevated input costs that reverberated through pricing strategies and profit margins. In response, many suppliers expedited efforts to diversify their vendor networks, engaging with partners across alternative regions to secure stable material supply at competitive rates.

Moreover, the cost pressures induced by tariff escalation prompted end users to reevaluate inventory management practices and procurement cycles. Diagnostic laboratories and point-of-care providers sought to consolidate orders, pursue volume discounts, and negotiate long-term agreements to mitigate the impact of fluctuating import duties. Concurrently, leading assay developers intensified in-country manufacturing initiatives and strategic partnerships with local producers, thereby reducing exposure to cross-border levies and strengthening supply chain resilience.

These realignments have stimulated investment in nearshore manufacturing facilities and automation technologies that lower dependency on volatile trade routes. At the same time, regulatory agencies have adjusted compliance frameworks to facilitate rapid registration of domestically produced assay kits. Through these collective measures, the industry continues to adapt to tariff-driven challenges while preserving the accessibility and affordability of lateral flow diagnostics on a global scale.

Deciphering Core Segmentation Insights by Product Sample Format Technique Application and End User to Enhance Precision Strategies in Assay Development

A nuanced understanding of assay market segmentation is critical for stakeholders seeking targeted growth opportunities and precision positioning. When analyzed by product type, kits remain the primary revenue driver, while readers gain traction through digital enhancements and connectivity features, and reagents and consumables maintain steady demand due to routine assay maintenance and quality control needs. Shifting attention to sample type reveals that whole blood continues to dominate clinical diagnostics, but emerging interest in saliva-based assays reflects the pursuit of noninvasive testing solutions. Serum and plasma applications underpin lipid and cholesterol panels, whereas urine screening remains essential for drug abuse testing and infectious disease surveillance.

Format selection also influences market pathways: cassette configurations appeal to home care and point-of-care testing environments for their user-friendly design, strip formats support high-volume clinical settings through streamlined workflows, and well plate layouts integrate seamlessly into automated laboratory platforms. Across assay techniques, sandwich immunoassays hold prominence in infectious disease detection, competitive assays serve small-molecule screening needs, and multiplex platforms address simultaneous biomarker analysis for comprehensive diagnostic insights. Application segmentation underscores the versatility of lateral flow assays, with environmental testing detecting waterborne contaminants, food safety monitoring ensuring supply chain integrity, veterinary testing bolstering animal health surveillance, and quality control checks safeguarding manufacturing processes. Clinical diagnostics remains the largest application arena, driven by subsegments such as cardiac marker evaluation, drug abuse panels, infectious disease screening, lipid profiling, and fertility assessments. Finally, end users span diagnostic laboratories, hospitals and clinics, research institutes, home care providers, and point-of-care testing facilities.

By mapping these dimensions, organizations can refine product development, prioritize market entry efforts, and tailor marketing strategies to address the distinct requirements of each segment.

Analyzing Regional Variations in Demand Technological Adoption and Regulatory Environments Across the Americas Europe Middle East Africa and Asia-Pacific

Regional dynamics play a pivotal role in shaping the lateral flow assay market's trajectory. In the Americas, robust healthcare infrastructure and proactive regulatory agencies have fostered rapid adoption of innovative point-of-care diagnostics. Public health initiatives and reimbursement frameworks continue to incentivize decentralized testing, supporting widespread deployment in community clinics and retail health centers. Cross-border trade agreements have similarly facilitated the flow of assay components and enhanced collaborative research networks across North and Latin America.

Turning to Europe, the Middle East, and Africa, market growth exhibits notable heterogeneity driven by diverse healthcare expenditure levels and regulatory landscapes. While Western European nations integrate digital readout devices into standardized care pathways, emerging economies in the Middle East and Africa prioritize low-cost, easy-to-use assays for infectious disease monitoring and maternal health programs. Harmonized approval processes within regional economic communities streamline product registration, yet localized certification requirements necessitate tailored market entry tactics.

In the Asia-Pacific region, manufacturing capabilities and government modernization programs have positioned several countries as leading production hubs for lateral flow devices. National health campaigns and pandemic preparedness initiatives have further accelerated uptake of rapid diagnostics in China, India, Japan, and Southeast Asia. Incentives for domestic innovation, coupled with strategic export policies, enable manufacturers to scale operations and serve both local and international demand. These regional distinctions underscore the need for customized strategies that address regulatory complexity, distribution infrastructure, and evolving end-user preferences.

Highlighting Strategic Moves Competitive Positioning and Collaborative Partnerships of Leading Companies Shaping the Future of the Lateral Flow Assay Market

The competitive landscape of lateral flow assays is defined by a mix of established diagnostics leaders, specialized reagent suppliers, and agile startups. Leading diagnostics corporations have leveraged their extensive distribution networks to introduce advanced reader systems and multiplex panels, integrating connectivity features that augment their traditional kit portfolios. In parallel, dedicated reagent manufacturers focus on refining antibody specificity and membrane technologies, enabling end-users to achieve higher analytical performance. Startups and niche players contribute to market dynamism by pioneering novel labeling agents such as up-converting phosphors and quantum dots, expanding the range of detectable targets.

Collaborative partnerships have become a strategic imperative, with cross-industry alliances bridging diagnostics firms, academic institutions, and technology providers. These collaborations accelerate product development cycles, facilitate knowledge transfer, and support co-development of integrated hardware-software solutions. Moreover, mergers and acquisitions serve as a conduit for portfolio expansion, allowing companies to integrate complementary assay formats and diversify application coverage. Licensing agreements further enable early-stage innovators to scale manufacturing and distribution, while multi-stakeholder consortia drive standardization efforts and regulatory harmonization.

As a result, market leaders that align R&D investments with customer-centric offerings, forge strategic alliances, and maintain agile supply chains will be best positioned to capture growth, respond to emerging health threats, and set new performance benchmarks.

Presenting Actionable Strategic Recommendations for Industry Leaders to Drive Growth Optimize Operations and Leverage Emerging Opportunities in Lateral Flow Assays

To navigate the evolving lateral flow assay marketplace and secure a competitive edge, industry leaders should prioritize a series of strategic actions. First, investing in digital reader technologies and data analytics platforms will unlock new opportunities for remote monitoring, patient engagement, and real-time epidemiological insights. Secondly, diversifying manufacturing footprints through nearshoring or multi-region facilities mitigates tariff risks and enhances supply chain resiliency. Third, fostering collaborative partnerships with antibody and membrane material innovators accelerates development timelines and strengthens proprietary assay performance.

In addition, firms should explore multiplexing capabilities to address growing demand for comprehensive biomarker panels that streamline workflows and reduce per-test costs. Targeted expansion into emerging markets in Africa and Southeast Asia requires engagement with local stakeholders, adaptation to regional regulatory frameworks, and development of cost-effective assay formats. Strengthening post-market surveillance and quality management processes will ensure compliance and build customer trust. Finally, aligning commercial strategies with personalized medicine trends-such as companion diagnostics for targeted therapies-can open new revenue streams and reinforce long-term relevance.

By implementing these recommendations in a coordinated manner, organizations can drive sustainable growth, foster innovation synergies, and deliver high-impact solutions that meet the evolving needs of healthcare providers and end users.

Outlining a Comprehensive Research Methodology Combining Qualitative and Quantitative Approaches Expert Interviews and Data Triangulation to Ensure Analytical Rigor

The research underpinning this analysis employs a rigorous, multi-stage methodology designed to ensure both breadth and depth of insight. Initially, primary qualitative data were collected through in-depth interviews with more than fifty industry experts, including R&D heads, regulatory specialists, procurement managers, and end-user representatives. These interviews provided nuanced perspectives on technological trends, market drivers, and operational challenges. In parallel, secondary research encompassed a comprehensive review of peer-reviewed journals, regulatory agency publications, patent filings, and technical whitepapers, enabling triangulation of quantitative market indicators and qualitative findings.

Subsequently, a structured data-triangulation approach synthesized information across multiple sources to validate key trends and corroborate expert viewpoints. The research team mapped segmentation dimensions-product type, sample type, format, technique, application, and end user-and cross-referenced these with regional, competitive, and policy dynamics. Advanced analytical tools facilitated scenario analysis, competitive benchmarking, and supply chain modeling, ensuring robust interpretations of tariff impacts and strategic implications.

Throughout the process, the methodology adhered to stringent quality protocols, including peer reviews, data validation checks, and iterative feedback loops with subject matter experts. This comprehensive framework delivers a dependable foundation for strategic decision-making and offers stakeholders clarity on the complex factors shaping the lateral flow assay market.

Concluding Key Takeaways Emphasizing Strategic Imperatives Innovation Pathways and Growth Prospects for Stakeholders in the Dynamic Lateral Flow Assay Landscape

In summary, lateral flow assays stand at the forefront of rapid diagnostic innovation, fueled by advancements in materials science, digital integration, and multiplexing capabilities. The imposition of tariffs in 2025 has catalyzed supply chain diversification, nearshore production, and procurement optimization, underscoring the importance of agility and resilience. Detailed segmentation analysis reveals differentiated growth pathways across product types, sample matrices, assay formats, and application domains, while regional insights highlight the strategic nuances of the Americas, Europe, Middle East, Africa, and Asia-Pacific markets.

Competitive dynamics continue to evolve as established diagnostics firms, specialized reagent developers, and pioneering startups vie for market leadership through strategic partnerships, product innovation, and portfolio expansion. To thrive in this dynamic environment, industry participants must invest in digital readers, fortify supply chains against trade disruptions, and pursue collaborative ventures that accelerate innovation. Customized strategies that address regional regulatory contexts and end-user requirements will be instrumental in capturing growth and delivering high-impact solutions.

By embracing these strategic imperatives and leveraging the insights presented, stakeholders are well positioned to navigate the complexities of the lateral flow assay ecosystem, drive sustainable growth, and enhance patient outcomes through rapid, accurate, and accessible diagnostics.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Integration of smartphone-based quantitative readers for multiplexed lateral flow assays to enable real-time data analytics
  • 5.2. Development of biodegradable and eco-friendly lateral flow assay membranes to reduce environmental impact
  • 5.3. Adoption of CRISPR-based signal amplification in lateral flow diagnostics for enhanced sensitivity in point-of-care testing
  • 5.4. Expansion of at-home infectious disease testing panels using multiplex lateral flow platforms for respiratory pathogens
  • 5.5. Implementation of AI-driven image analysis in lateral flow test readers to improve result interpretation accuracy
  • 5.6. Partnerships between central laboratories and lateral flow assay manufacturers to standardize quality control protocols
  • 5.7. Emergence of fully digitalized supply chain management for rapid distribution of lateral flow assay components
  • 5.8. Growth of personalized medicine applications using lateral flow tests for biomarker monitoring in chronic disease management

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Lateral Flow Assays Market, by Product Type

  • 8.1. Introduction
  • 8.2. Kits
  • 8.3. Readers
  • 8.4. Reagents & Consumables

9. Lateral Flow Assays Market, by Sample Type

  • 9.1. Introduction
  • 9.2. Saliva
  • 9.3. Serum & Plasma
  • 9.4. Urine
  • 9.5. Whole Blood

10. Lateral Flow Assays Market, by Format

  • 10.1. Introduction
  • 10.2. Cassette
  • 10.3. Strip
  • 10.4. Well Plate

11. Lateral Flow Assays Market, by Technique

  • 11.1. Introduction
  • 11.2. Competitive Assays
  • 11.3. Multiplex Assays
  • 11.4. Sandwich Assays

12. Lateral Flow Assays Market, by Application

  • 12.1. Introduction
  • 12.2. Clinical Diagnostics
    • 12.2.1. Cardiac Marker Testing
    • 12.2.2. Drug of Abuse Testing
    • 12.2.3. Infectious Diseases
    • 12.2.4. Lipid/Cholesterol Testing
    • 12.2.5. Pregnancy & Fertility Testing
  • 12.3. Environmental Testing
  • 12.4. Food Safety
  • 12.5. Quality Control
  • 12.6. Veterinary Testing

13. Lateral Flow Assays Market, by End User

  • 13.1. Introduction
  • 13.2. Diagnostic Laboratories
  • 13.3. Home Care
  • 13.4. Hospitals & Clinics
  • 13.5. Point Of Care Testing
  • 13.6. Research Institutes

14. Americas Lateral Flow Assays Market

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. Argentina

15. Europe, Middle East & Africa Lateral Flow Assays Market

  • 15.1. Introduction
  • 15.2. United Kingdom
  • 15.3. Germany
  • 15.4. France
  • 15.5. Russia
  • 15.6. Italy
  • 15.7. Spain
  • 15.8. United Arab Emirates
  • 15.9. Saudi Arabia
  • 15.10. South Africa
  • 15.11. Denmark
  • 15.12. Netherlands
  • 15.13. Qatar
  • 15.14. Finland
  • 15.15. Sweden
  • 15.16. Nigeria
  • 15.17. Egypt
  • 15.18. Turkey
  • 15.19. Israel
  • 15.20. Norway
  • 15.21. Poland
  • 15.22. Switzerland

16. Asia-Pacific Lateral Flow Assays Market

  • 16.1. Introduction
  • 16.2. China
  • 16.3. India
  • 16.4. Japan
  • 16.5. Australia
  • 16.6. South Korea
  • 16.7. Indonesia
  • 16.8. Thailand
  • 16.9. Philippines
  • 16.10. Malaysia
  • 16.11. Singapore
  • 16.12. Vietnam
  • 16.13. Taiwan

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Abbott Laboratories
    • 17.3.2. Abcam PLC by Danaher Corporation
    • 17.3.3. Becton, Dickinson and Company
    • 17.3.4. Bio-Rad Laboratories, Inc.
    • 17.3.5. Bio-Techne Corporation
    • 17.3.6. BioMerieux SA
    • 17.3.7. BioPorto Diagnostics A/S
    • 17.3.8. Cytodiagnostics Inc.
    • 17.3.9. Danaher Corporation
    • 17.3.10. Elabscience Bionovation Inc.
    • 17.3.11. F. Hoffmann-La Roche Ltd.
    • 17.3.12. Fortis Life Sciences
    • 17.3.13. Hologic, Inc.
    • 17.3.14. Merck KGaA
    • 17.3.15. Microcoat Biotechnologie GmbH
    • 17.3.16. PerkinElmer Inc.
    • 17.3.17. Porex Corporation by Filtration Group Corporation
    • 17.3.18. QIAGEN N.V.
    • 17.3.19. QuidelOrtho Corporation
    • 17.3.20. Siemens Healthineers AG
    • 17.3.21. Thermo Fisher Scientific Inc.
    • 17.3.22. Leinco Technologies, Inc.
    • 17.3.23. R-Biopharm AG
    • 17.3.24. Suzhou Vdo Biotech Co.,Ltd.
    • 17.3.25. Rockland Immunochemicals, Inc.
    • 17.3.26. BBI Solutions
    • 17.3.27. BioFluidix GmbH by Hamilton Company
    • 17.3.28. Tetracore, Inc.
    • 17.3.29. Milenia Biotec GmbH
    • 17.3.30. Shenzhen SEKBIO Co., Ltd.

18. ResearchAI

19. ResearchStatistics

20. ResearchContacts

21. ResearchArticles

22. Appendix

LIST OF FIGURES

  • FIGURE 1. LATERAL FLOW ASSAYS MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 16. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 20. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. ASIA-PACIFIC LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 24. ASIA-PACIFIC LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 25. LATERAL FLOW ASSAYS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. LATERAL FLOW ASSAYS MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 27. LATERAL FLOW ASSAYS MARKET: RESEARCHAI
  • FIGURE 28. LATERAL FLOW ASSAYS MARKET: RESEARCHSTATISTICS
  • FIGURE 29. LATERAL FLOW ASSAYS MARKET: RESEARCHCONTACTS
  • FIGURE 30. LATERAL FLOW ASSAYS MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. LATERAL FLOW ASSAYS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY KITS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY READERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY READERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SALIVA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SERUM & PLASMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SERUM & PLASMA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY CASSETTE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY CASSETTE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY STRIP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY STRIP, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY WELL PLATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY WELL PLATE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY COMPETITIVE ASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY COMPETITIVE ASSAYS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY MULTIPLEX ASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY MULTIPLEX ASSAYS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SANDWICH ASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SANDWICH ASSAYS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY CARDIAC MARKER TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY CARDIAC MARKER TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY DRUG OF ABUSE TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY DRUG OF ABUSE TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY LIPID/CHOLESTEROL TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY LIPID/CHOLESTEROL TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY FOOD SAFETY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY FOOD SAFETY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY VETERINARY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY VETERINARY TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 80. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 81. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 82. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 83. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
  • TABLE 84. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
  • TABLE 85. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 86. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 87. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 88. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 89. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 90. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 91. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 92. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 93. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 95. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 96. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 97. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 98. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 99. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
  • TABLE 100. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
  • TABLE 101. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 102. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 103. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 104. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 105. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 106. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 107. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 108. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 109. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 110. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 111. CANADA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 112. CANADA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 113. CANADA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 114. CANADA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 115. CANADA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
  • TABLE 116. CANADA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
  • TABLE 117. CANADA LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 118. CANADA LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 119. CANADA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 120. CANADA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 121. CANADA LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 122. CANADA LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 123. CANADA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 124. CANADA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 125. MEXICO LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 126. MEXICO LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 127. MEXICO LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. MEXICO LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 129. MEXICO LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
  • TABLE 130. MEXICO LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
  • TABLE 131. MEXICO LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 132. MEXICO LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 133. MEXICO LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 134. MEXICO LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 135. MEXICO LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 136. MEXICO LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 137. MEXICO LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 138. MEXICO LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 139. BRAZIL LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. BRAZIL LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 141. BRAZIL LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. BRAZIL LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 143. BRAZIL LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
  • TABLE 144. BRAZIL LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
  • TABLE 145. BRAZIL LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 146. BRAZIL LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 147. BRAZIL LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 148. BRAZIL LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 149. BRAZIL LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 150. BRAZIL LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 151. BRAZIL LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 152. BRAZIL LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 153. ARGENTINA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. ARGENTINA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 155. ARGENTINA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. ARGENTINA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 157. ARGENTINA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
  • TABLE 158. ARGENTINA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
  • TABLE 159. ARGENTINA LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 160. ARGENTINA LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 161. ARGENTINA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 162. ARGENTINA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 163. ARGENTINA LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 164. ARGENTINA LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 165. ARGENTINA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. ARGENTINA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. UNITED KINGDOM LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. UNITED KINGDOM LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
  • TABLE 188. UNITED KINGDOM LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 190. UNITED KINGDOM LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. UNITED KINGDOM LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 194. UNITED KINGDOM LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. UNITED KINGDOM LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 197. GERMANY LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. GERMANY LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 199. GERMANY LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. GERMANY LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 201. GERMANY LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
  • TABLE 202. GERMANY LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
  • TABLE 203. GERMANY LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 204. GERMANY LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 205. GERMANY LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. GERMANY LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 207. GERMANY LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 208. GERMANY LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 209. GERMANY LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. GERMANY LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 211. FRANCE LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. FRANCE LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 213. FRANCE LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. FRANCE LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 215. FRANCE LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
  • TABLE 216. FRANCE LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
  • TABLE 217. FRANCE LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 218. FRANCE LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 219. FRANCE LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. FRANCE LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 221. FRANCE LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 222. FRANCE LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 223. FRANCE LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. FRANCE LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 225. RUSSIA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. RUSSIA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 227. RUSSIA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. RUSSIA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 229. RUSSIA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
  • TABLE 230. RUSSIA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
  • TABLE 231. RUSSIA LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 232. RUSSIA LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 233. RUSSIA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. RUSSIA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 235. RUSSIA LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 236. RUSSIA LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 237. RUSSIA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. RUSSIA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 239. ITALY LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. ITALY LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 241. ITALY LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. ITALY LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 243. ITALY LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
  • TABLE 244. ITALY LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
  • TABLE 245. ITALY LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 246. ITALY LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 247. ITALY LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. ITALY LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 249. ITALY LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 250. ITALY LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 251. ITALY LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 252. ITALY LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 253. SPAIN LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. SPAIN LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 255. SPAIN LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. SPAIN LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 257. SPAIN LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
  • TABLE 258. SPAIN LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
  • TABLE 259. SPAIN LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 260. SPAIN LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 261. SPAIN LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. SPAIN LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 263. SPAIN LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 264. SPAIN LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 265. SPAIN LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. SPAIN LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. SAUDI ARABIA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 283. SAUDI ARABIA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. SAUDI ARABIA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 285. SAUDI ARABIA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
  • TABLE 286. SAUDI ARABIA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
  • TABLE 287. SAUDI ARABIA LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 288. SAUDI ARABIA LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 289. SAUDI ARABIA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. SAUDI ARABIA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 291. SAUDI ARABIA LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 292. SAUDI ARABIA LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 293. SAUDI ARABIA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 294. SAUDI ARABIA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 295. SOUTH AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. SOUTH AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 297. SOUTH AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. SOUTH AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 299. SOUTH AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
  • TABLE 300. SOUTH AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
  • TABLE 301. SOUTH AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 302. SOUTH AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 303. SOUTH AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 304. SOUTH AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 305. SOUTH AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 306. SOUTH AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 307. SOUTH AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. SOUTH AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 309. DENMARK LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. DENMARK LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 311. DENMARK LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 312. DENMARK LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 313. DENMARK LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
  • TABLE 314. DENMARK LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
  • TABLE 315. DENMARK LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 316. DENMARK LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 317. DENMARK LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 318. DENMARK LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 319. DENMARK LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 320. DENMARK LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 321. DENMARK LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 322. DENMARK LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 323. NETHERLANDS LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 324. NETHERLANDS LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. NETHERLANDS LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 327. NETHERLANDS LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
  • TABLE 328. NETHERLANDS LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
  • TABLE 329. NETHERLANDS LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 330. NETHERLANDS LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 331. NETHERLANDS LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 332. NETHERLANDS LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 333. NETHERLANDS LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 334. NETHERLANDS LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 335. NETHERLANDS LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 336. NETHERLANDS LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 337. QATAR LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 338. QATAR LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 339. QATAR LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. QATAR LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 341. QATAR LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
  • TABLE 342. QATAR LATERAL FLOW ASSAYS MARK